Drug Approval | November 22, 2021
European Commission approves Roche’s Gavreto
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Vakrangee’s distribution network across rural India will help penetrate underserved markets
The 50-bed hospital is positioned to address complexities specific to women and children, going beyond a birthing facility
The rise in cases amongst the young is a cause for concern. A few specialists gave us a perspective on the issue
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
Trivector Biomed has been promoting its Novaerus air disinfection solution across hospitals and health care facilities across India.
The NFI is published to promote the rational use of medicines in the country.
This unique record was made possible by collating hard copies of the books in a structured manner
Subscribe To Our Newsletter & Stay Updated
